Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julia Di

Showing results (41-50 of 81) with videos related to

Pageof 9
Sort By:
Hepatology (Baltimore, Md.)|January 20, 2011
Effect of immune pressure on hepatitis C virus evolution: insights from a single-source outbreakShahzma Merani, Danijela Petrovic, Ian James, et al.
Pharmacogenetics and Genomics|February 9, 2010
ADME pharmacogenetics: investigation of the pharmacokinetics of the antiretroviral agent lopinavir coformulated with ritonavirRubin Lubomirov, Julia di Iulio, Aurélie Fayet, et al.
Antimicrobial Agents and Chemotherapy|February 29, 2012
Population pharmacokinetic analysis and pharmacogenetics of raltegravir in HIV-positive and healthy individualsMona Arab-Alameddine, Aurélie Fayet-Mello, Rubin Lubomirov, et al.
Hepatology (Baltimore, Md.)|March 2, 2011
Estimating the net contribution of interleukin-28B variation to spontaneous hepatitis C virus clearanceJulia di Iulio, Angela Ciuffi, Karen Fitzmaurice, et al.
Nature Genetics|February 28, 2018
The human noncoding genome defined by genetic diversityJulia di Iulio, Istvan Bartha, Emily H M Wong, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 10, 2006
Relationship of hepatic functional imaging to irinotecan pharmacokinetics and genetic parameters of drug eliminationMichael Michael, Mick Thompson, Rod J Hicks, et al.
Pharmacogenetics and Genomics|November 1, 2012
Pharmacogenetics-based population pharmacokinetic analysis of etravirine in HIV-1 infected individualsRubin Lubomirov, Mona Arab-Alameddine, Margalida Rotger, et al.
Science Translational Medicine|January 11, 2022
Predicting the mutational drivers of future SARS-CoV-2 variants of concernM Cyrus Maher, Istvan Bartha, Steven Weaver, et al.
Cell Reports. Medicine|May 5, 2021
Analysis of Brugada syndrome loci reveals that fine-mapping clustered GWAS hits enhances the annotation of disease-relevant variantsMel Lina Pinsach-Abuin, Bernat Del Olmo, Adrian Pérez-Agustin, et al.
Frontiers in Oncology|April 3, 2023
Prospective study: Impact of breast magnetic resonance imaging on oncoplastic surgery and on indications of mastectomy in patients who were previously candidates to breast conserving surgeryKarina Furlan Anselmi, Cicero Urban, Maíra Teixeira Dória, et al.
Pageof 9

Showing results (41-50 of 81) with videos related to

Sort By:
Pageof 9
Hepatology (Baltimore, Md.)|January 20, 2011
Effect of immune pressure on hepatitis C virus evolution: insights from a single-source outbreakShahzma Merani, Danijela Petrovic, Ian James, et al.
Pharmacogenetics and Genomics|February 9, 2010
ADME pharmacogenetics: investigation of the pharmacokinetics of the antiretroviral agent lopinavir coformulated with ritonavirRubin Lubomirov, Julia di Iulio, Aurélie Fayet, et al.
Antimicrobial Agents and Chemotherapy|February 29, 2012
Population pharmacokinetic analysis and pharmacogenetics of raltegravir in HIV-positive and healthy individualsMona Arab-Alameddine, Aurélie Fayet-Mello, Rubin Lubomirov, et al.
Hepatology (Baltimore, Md.)|March 2, 2011
Estimating the net contribution of interleukin-28B variation to spontaneous hepatitis C virus clearanceJulia di Iulio, Angela Ciuffi, Karen Fitzmaurice, et al.
Nature Genetics|February 28, 2018
The human noncoding genome defined by genetic diversityJulia di Iulio, Istvan Bartha, Emily H M Wong, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 10, 2006
Relationship of hepatic functional imaging to irinotecan pharmacokinetics and genetic parameters of drug eliminationMichael Michael, Mick Thompson, Rod J Hicks, et al.
Pharmacogenetics and Genomics|November 1, 2012
Pharmacogenetics-based population pharmacokinetic analysis of etravirine in HIV-1 infected individualsRubin Lubomirov, Mona Arab-Alameddine, Margalida Rotger, et al.
Science Translational Medicine|January 11, 2022
Predicting the mutational drivers of future SARS-CoV-2 variants of concernM Cyrus Maher, Istvan Bartha, Steven Weaver, et al.
Cell Reports. Medicine|May 5, 2021
Analysis of Brugada syndrome loci reveals that fine-mapping clustered GWAS hits enhances the annotation of disease-relevant variantsMel Lina Pinsach-Abuin, Bernat Del Olmo, Adrian Pérez-Agustin, et al.
Frontiers in Oncology|April 3, 2023
Prospective study: Impact of breast magnetic resonance imaging on oncoplastic surgery and on indications of mastectomy in patients who were previously candidates to breast conserving surgeryKarina Furlan Anselmi, Cicero Urban, Maíra Teixeira Dória, et al.
Pageof 9